Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

Investing

Merck : MRK

All Merck Articles

1079 Articles

Paul Ausick | Oct 20, 2018 at 8:55 AM EDT

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

Apple shares dipped again last week, but the company managed to hold onto its rank as the top-performing Dow stock…

Chris Lange | Oct 16, 2018 at 10:15 AM EDT

Merck’s Pancreatic Cancer Treatment Gets FDA Nod

Merck shares were up handily on Tuesday after the company announced a key update from the FDA on its Lynparza…

Jon C. Ogg | Oct 16, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Adobe, BofA, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX, Valero and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Adobe, Bank of America, Boston Scientific, Facebook, Las Vegas…

Paul Ausick | Oct 13, 2018 at 8:35 AM EDT

Apple Repeats as Top-Performing Dow Stock

Apple survived a bloody week in the markets to return as the best-performing Dow Jones industrial stock for the year…

Jon C. Ogg | Oct 11, 2018 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Abercrombie, CME, Costco, DowDuPont, Gap, HCA, Herbalife, Merck, PayPal, Urban Outfitters and More

The top analyst upgrades, downgrades and initiations seen on Thursday included Abercrombie & Fitch, CME, Costco, DowDuPont, Gap, HCA, Herbalife,…

Chris Lange | Oct 10, 2018 at 9:10 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Chris Lange | Oct 6, 2018 at 7:55 AM EDT

Major Biopharma Catalysts to Watch For in October

Here 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates…

Lee Jackson | Oct 2, 2018 at 8:45 AM EDT

Analyst Has 5 Stocks to Buy Now With Big Q4 Upside Potential

These five well-known stocks may be laggards but they look like they have solid upside potential, and all can help…

Chris Lange | Sep 29, 2018 at 8:15 AM EDT

Major Biopharma Catalysts on October’s FDA Calendar

Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month…

Chris Lange | Sep 26, 2018 at 8:50 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Paul Ausick | Sep 15, 2018 at 8:45 AM EDT

Nike Sprints to First Place as Dow’s Top-Performing Stock

Nike's risky new ad campaign featuring NFL player Colin Kaepernick has paid off in higher sales and increased attention from…

Paul Ausick | Sep 13, 2018 at 4:01 PM EDT

Apple, IBM Lift the Dow Thursday

Apple, IBM, Merck, and Travelers buoyed the Dow index on Thursday.

Chris Lange | Sep 13, 2018 at 9:55 AM EDT

Short Sellers Back Off Major Pharma Stocks

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Sep 8, 2018 at 8:35 AM EDT

Apple Rolls on as Dow’s Top-Performing Stock

Apple held on to its position as the best performing Dow stock for the year to date last week. Next…

Paul Ausick | Sep 6, 2018 at 4:01 PM EDT

Boeing, Visa Prop Up the Dow Thursday

Boeing, Visa, Merck, and Verizon posted large enough gains to keep the Dow in the green Thursday.

1 … 19 20 21 22 23 … 72

Merck : MRK

All Merck Articles

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

Merck’s Pancreatic Cancer Treatment Gets FDA Nod

Top Analyst Upgrades and Downgrades: Adobe, BofA, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX, Valero and More

Apple Repeats as Top-Performing Dow Stock

Top Analyst Upgrades and Downgrades: Abercrombie, CME, Costco, DowDuPont, Gap, HCA, Herbalife, Merck, PayPal, Urban Outfitters and More

Short Sellers Run for Cover From Major Pharma

Major Biopharma Catalysts to Watch For in October

Analyst Has 5 Stocks to Buy Now With Big Q4 Upside Potential

Major Biopharma Catalysts on October’s FDA Calendar

Short Sellers Grow More Selective on Major Pharma Stocks

Nike Sprints to First Place as Dow’s Top-Performing Stock

Apple, IBM Lift the Dow Thursday

Short Sellers Back Off Major Pharma Stocks

Apple Rolls on as Dow’s Top-Performing Stock

Boeing, Visa Prop Up the Dow Thursday

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Merck : MRK

All Merck Articles

Apple Again Top-Performing Dow Stock, but Merck Is Closing In

Merck’s Pancreatic Cancer Treatment Gets FDA Nod

Top Analyst Upgrades and Downgrades: Adobe, BofA, Boston Scientific, Facebook, Las Vegas Sands, Merck, Tilray, TJX, Valero and More

Apple Repeats as Top-Performing Dow Stock

Top Analyst Upgrades and Downgrades: Abercrombie, CME, Costco, DowDuPont, Gap, HCA, Herbalife, Merck, PayPal, Urban Outfitters and More

Short Sellers Run for Cover From Major Pharma

Major Biopharma Catalysts to Watch For in October

Analyst Has 5 Stocks to Buy Now With Big Q4 Upside Potential

Major Biopharma Catalysts on October’s FDA Calendar

Short Sellers Grow More Selective on Major Pharma Stocks

Nike Sprints to First Place as Dow’s Top-Performing Stock

Apple, IBM Lift the Dow Thursday

Short Sellers Back Off Major Pharma Stocks

Apple Rolls on as Dow’s Top-Performing Stock

Boeing, Visa Prop Up the Dow Thursday

Live: Will Oracle Crush Q4 Earnings After the Market Closes Tonight?

3 Dividend Stocks Built for Retirement to Buy in June

From PC Maker to AI Giant: How Dell Rewarded Patient Investors With Nearly 1,900% Gains and AI Capex Determines The Future

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation